Geneos Wealth Management Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$646
-61.1%
400.0%0.00%
Q2 2023$1,660
-72.3%
40
-55.6%
0.00%
Q3 2022$6,000
-33.3%
90
-33.3%
0.00%
Q2 2022$9,000
-18.2%
1350.0%0.00%
Q1 2022$11,000
+10.0%
135
-6.9%
0.00%
Q4 2021$10,000
+66.7%
145
-27.5%
0.00%
Q4 2018$6,000
+500.0%
200
+100.0%
0.00%
Q1 2016$1,0001000.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders